OraSure Technologies Announces $25 Million Share Repurchase Program
06 8월 2008 - 5:00AM
Business Wire
OraSure Technologies, Inc. (NASDAQ:OSUR), a market leader in oral
fluid diagnostics, today announced that its Board of Directors has
approved a share repurchase program to acquire up to $25 million of
its outstanding common shares. Purchases under the program will be
made at the Company�s discretion, subject to market conditions, in
the open market, in privately-negotiated transactions or otherwise,
including pursuant to a 10b5-1 plan, and will be made in accordance
with the regulations of the U.S. Securities and Exchange
Commission. The Company has made no commitment to purchase any
shares, and purchases may be discontinued at any time. About
OraSure Technologies OraSure Technologies develops, manufactures
and markets oral fluid specimen collection devices using
proprietary oral fluid technologies, diagnostic products including
immunoassays and other in vitro diagnostic tests, and other medical
devices. These products are sold in the United States as well as
internationally to various clinical laboratories, hospitals,
clinics, community-based organizations and other public health
organizations, distributors, government agencies, physicians�
offices, and commercial and industrial entities. OraSure
Technologies is the leading supplier of oral-fluid collection
devices and assays to the life insurance industry and public health
markets for the detection of antibodies to HIV. In addition, the
Company supplies oral-fluid testing solutions for drugs of abuse
testing. For more information on the Company, please go to
www.orasure.com.
OraSure Technologies (NASDAQ:OSUR)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
OraSure Technologies (NASDAQ:OSUR)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024